Income Statement - Kymera Therapeutics, Inc. (KYMR)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | |
|---|---|---|---|---|---|---|---|---|
| Total revenue | 39.20 | 47.07 | 78.59 | 46.83 | 72.83 | 34.03 | 2.93 | 0.00 |
| Cost of revenue | 7.37 | 189.08 | 2.98 | 2.40 | 62.11 | 0.83 | 0.21 | |
| Gross profit | 39.20 | 47.07 | 78.59 | 46.83 | 72.83 | 34.03 | 2.11 | -0.21 |
| Total operating expenses | 388.60 | 308.71 | 244.12 | 208.08 | 173.36 | 80.34 | 45.14 | 21.45 |
| Operating income | -349.40 | -261.64 | -165.53 | -161.26 | -100.53 | -46.30 | -42.21 | -21.45 |
| Non-operating income (net) | 37.78 | 37.78 | 18.57 | 6.45 | 0.31 | 0.71 | 0.96 | -0.02 |
| Income before tax | -311.62 | -223.86 | -146.96 | -154.81 | -100.22 | -45.59 | -41.25 | -21.47 |
| Income tax expense | 18.76 | -2.98 | -2.22 | -1.65 | 0.05 | 0.04 | ||
| Net income | -311.40 | -223.86 | -146.96 | -154.81 | -100.22 | -45.59 | -41.29 | -21.47 |
Show Quarterly Income Statement
Income Statement - Kymera Therapeutics, Inc. (KYMR)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | Dec-19 | Sep-19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 34.37 | 2.86 | 2.76 | 11.48 | 22.10 | 7.39 | 3.74 | 25.65 | 10.29 | 47.89 | 4.73 | 16.51 | 9.47 | 16.14 | 9.55 | 11.51 | 9.62 | 15.28 | 20.34 | 18.52 | 18.70 | 12.79 | 14.53 | 3.29 | 3.43 | 1.83 | 0.95 |
| Cost of revenue | 2.02 | -76.18 | 74.09 | 2.08 | 2.05 | 1.97 | 2.00 | 1.90 | 1.50 | 0.87 | 0.90 | 0.90 | 0.90 | 0.82 | 43.88 | 0.70 | |||||||||||
| Gross profit | 34.37 | 79.04 | -71.33 | 9.39 | 22.10 | 7.39 | 3.74 | 25.65 | 10.29 | 47.89 | 4.73 | 16.51 | 9.47 | 16.14 | 9.55 | 11.51 | 9.62 | 15.28 | 20.34 | 18.52 | 18.70 | 12.79 | 14.53 | 3.29 | 3.43 | 1.83 | 0.95 |
| Total operating expenses | 118.52 | 176.93 | 21.19 | 93.95 | 96.53 | 88.15 | 75.87 | 76.58 | 68.12 | 67.20 | 62.24 | 59.90 | 54.79 | 54.77 | 54.43 | 52.32 | 46.56 | 49.27 | 48.97 | 43.25 | 31.87 | 25.57 | 22.62 | 17.48 | 14.68 | 13.62 | 12.81 |
| Operating income | -84.15 | -97.90 | -92.52 | -84.56 | -74.43 | -80.76 | -72.12 | -50.93 | -57.83 | -19.31 | -57.51 | -43.38 | -45.33 | -38.63 | -44.88 | -40.81 | -36.93 | -33.99 | -28.64 | -24.73 | -13.17 | -12.78 | -8.08 | -14.19 | -11.25 | -11.78 | -11.86 |
| Non-operating income (net) | 14.92 | 10.64 | 10.35 | 7.94 | 8.85 | 10.00 | 9.64 | 8.86 | 9.27 | 4.94 | 4.64 | 4.58 | 4.40 | 3.77 | 1.88 | 0.55 | 0.25 | 0.09 | 0.06 | 0.07 | 0.09 | 0.10 | 0.10 | 0.20 | 0.32 | 0.27 | 0.44 |
| Income before tax | -69.23 | -87.25 | -82.18 | -76.61 | -65.58 | -70.75 | -62.49 | -42.06 | -48.56 | -14.37 | -52.87 | -38.80 | -40.93 | -34.87 | -43.00 | -40.26 | -36.68 | -33.90 | -28.58 | -24.66 | -13.08 | -12.69 | -7.99 | -13.99 | -10.93 | -11.51 | -11.42 |
| Income tax expense | -2.00 | 0.04 | 5.00 | -0.90 | 4.63 | -4.34 | -0.82 | 1.92 | -0.55 | -0.25 | 0.05 | 0.13 | 0.10 | 0.12 | -0.37 | 0.13 | 0.23 | 0.35 | 0.30 | 0.45 | |||||||
| Net income | -69.23 | -87.03 | -82.18 | -76.61 | -65.58 | -70.75 | -62.49 | -42.06 | -48.56 | -14.37 | -52.87 | -38.80 | -40.93 | -34.87 | -43.00 | -40.26 | -36.68 | -33.90 | -28.58 | -24.66 | -13.08 | -12.69 | -7.99 | -13.99 | -10.93 | -11.51 | -11.42 |